GeneDx Holdings Corp. Increase (Decrease) in Inventories
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Inventories of $3.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-03
- GeneDx Holdings Corp. increase (decrease) in inventories for the quarter ending 2026-06-30 was $5.66M.
- GeneDx Holdings Corp. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$1.69M, a 183.12% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in inventories for the quarter ending 2025-12-31 was $3.36M, a 640.97% increase year-over-year.
- GeneDx Holdings Corp. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.33M, a 379.25% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in inventories for fiscal 2025 was $3.44M, a 32.92% increase from fiscal 2024.
- GeneDx Holdings Corp. increase (decrease) in inventories for fiscal 2024 was $2.58M.
- GeneDx Holdings Corp. increase (decrease) in inventories for fiscal 2023 was -$975.00K.
- GeneDx Holdings Corp. increase (decrease) in inventories for fiscal 2022 was -$2.35M, a 122.12% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $3.97M 10-Q · filed 2026-08-03 | $7.34M derived: sum of 3 quarters · filed 2026-08-03 | $6.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$1.69M 10-Q · filed 2026-05-04 | $1.68M derived: sum of 2 quarters · filed 2026-05-04 | $343.00K derived: sum of 3 quarters · filed 2026-05-04 | -$285.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.03M derived: sum of 2 quarters · filed 2026-02-23 | $1.40M derived: sum of 3 quarters · filed 2026-08-03 | $3.44M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$1.96M derived: sum of 2 quarters · filed 2026-08-03 | $72.00K 10-Q · filed 2025-10-28 | $526.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.40M 10-Q · filed 2026-08-03 | $1.86M derived: sum of 3 quarters · filed 2026-08-03 | $2.33M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-04 | $2.49M derived: sum of 2 quarters · filed 2026-05-04 | $2.96M derived: sum of 3 quarters · filed 2026-05-04 | $1.74M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $931.00K derived: sum of 2 quarters · filed 2026-02-23 | -$292.00K derived: sum of 3 quarters · filed 2026-02-23 | $2.58M 10-K · filed 2026-02-23 |
| 2024-09-30 | $477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$746.00K derived: sum of 2 quarters · filed 2025-10-28 | $2.13M 10-Q · filed 2025-10-28 | $1.84M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.65M 10-Q · filed 2025-07-29 | $1.36M derived: sum of 3 quarters · filed 2026-02-23 | $193.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $2.88M 10-Q · filed 2025-04-30 | $2.58M derived: sum of 2 quarters · filed 2026-02-23 | $1.42M derived: sum of 3 quarters · filed 2026-02-23 | $3.23M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.46M derived: sum of 2 quarters · filed 2026-02-23 | $356.00K derived: sum of 3 quarters · filed 2026-02-23 | -$975.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $649.00K derived: sum of 2 quarters · filed 2024-10-29 | -$682.00K 10-Q · filed 2024-10-29 | -$8.27M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $486.00K 10-Q · filed 2024-07-30 | -$7.10M derived: sum of 3 quarters · filed 2024-07-30 | -$4.15M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | -$1.33M 10-Q · filed 2024-04-29 | -$8.92M derived: sum of 2 quarters · filed 2024-04-29 | -$5.96M derived: sum of 3 quarters · filed 2024-04-29 | -$6.58M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | -$7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$4.63M derived: sum of 2 quarters · filed 2024-02-23 | -$5.25M derived: sum of 3 quarters · filed 2024-02-23 | -$2.35M 10-K · filed 2024-02-23 |
| 2022-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $2.33M derived: sum of 2 quarters · filed 2023-11-03 | $5.24M 10-Q · filed 2023-11-03 | $8.53M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | -$622.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.28M 10-Q · filed 2023-08-08 | $5.57M derived: sum of 3 quarters · filed 2023-08-08 | $6.27M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $2.90M 10-Q · filed 2023-05-09 | $6.19M derived: sum of 2 quarters · filed 2023-05-09 | $6.90M derived: sum of 3 quarters · filed 2023-05-09 | $3.70M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.99M derived: sum of 2 quarters · filed 2023-03-16 | $796.00K derived: sum of 3 quarters · filed 2023-03-16 | $10.62M 10-K · filed 2023-03-16 |
| 2021-09-30 | $702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.49M derived: sum of 2 quarters · filed 2022-11-14 | $7.33M 10-Q · filed 2022-11-14 | $8.21M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | -$3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $6.63M 10-Q · filed 2022-08-15 | $7.51M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $9.83M 10-Q · filed 2022-05-12 | $10.70M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $8.98M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $8.11M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $7.97M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |